Stockscreener 앱 받기
0.524
1.22%
0.0063
시간 외 거래:
.50
-0.024
-4.58%
Abvc Biopharma Inc 주식(ABVC)의 최신 뉴스
ABVC BioPharma Seeks to Revolutionize Mental Health - GlobeNewswire
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21 - Marketscreener.com
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 24.2% in November - Defense World
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners - The Manila Times
ABVC BioPharma Secures $200,000 in First Cash Licensing - GlobeNewswire
ABVC BioPharma Secures Major Oncology Licensing Deal: $200K Initial Payment, Up to $50M in Future Royalties - StockTitan
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 79.2% - Defense World
ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024 - Defense World
ABVC BioPharma Inc. (ABVC) Quarterly 10-Q Report - Quartzy
ABVCABVC BioPharma, Inc. Latest Stock News & Market Updates - StockTitan
ABVC BioPharma Reports First Operational Profit in Q3 2024, Showcasing Significant Financial Improvement - Citybuzz
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones - The Manila Times
ABVC BioPharma Reports First-Ever Operational Profit, 2,352% Revenue Surge in Q3 | ABVC Stock News - StockTitan
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Increase in Short Interest - Defense World
ABVC BioPharma Enters into Agreement to Exercise Warrants at Reduced Price - Defense World
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
ABVC BioPharma secures additional licensing fees - Investing.com
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners - The Manila Times
ABVC BioPharma secures additional licensing fees By Investing.com - Investing.com UK
ABVC BioPharma Receives $50,000 in Incremental Licensing - GlobeNewswire
ABVC BioPharma switches to new independent accounting firm - Investing.com
ABVC BioPharma switches to new independent accounting firm By Investing.com - Investing.com UK
ABVC BioPharma Inc (ABVC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World
1832 Asset Management L.P. Has $21.08 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Avidity Biosciences initiated with a Buy at Goldman Sachs - TipRanks
ABB unveils number of investors with maximum and minimum stakes in shares - Trend News Agency
ABB (NYSE:ABBNY) Stock Price Passes Above 200 Day Moving Average of $52.74 - MarketBeat
Rhumbline Advisers Sells 495,177 Shares of Ambev S.A. (NYSE:ABEV) - Defense World
Abans Holdings shares: Aditya Birla Money estimates small-cap stock to give multibagger returns. Buy or avoid? | Stock Market News - Mint
ABB (NYSE:ABBNY) Shares Cross Above 200 Day Moving Average of $52.74 - Defense World
Abbott Laboratories (NYSE:ABT) Shares Up 0.3% - MarketBeat
Bank of Montreal Can Trims Stock Holdings in Abbott Laboratories (NYSE:ABT) - Defense World
J. Stern & Co. LLP Has $30.67 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abbott Laboratories (NYSE:ABT) Shares Acquired by Frank Rimerman Advisors LLC - Defense World
ABEV’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Xponance Inc. Has $24.89 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abans Holdings Limited gets buy call with target price of Rs 710 | Check details here - India.com
Asset Management Firm Abans Holdings Gets Buy Rating from Aditya Birla MoneyKnow Share Price Target - Times Now
DRW Securities LLC Sells 4,279 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Profund Advisors LLC Sells 114 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Sold by Davidson Kempner Capital Management LP - Defense World
It makes sense and dollars to buy ArriVent BioPharma Inc. (AVBP) stock - SETE News
Addus HomeCare price target raised to $145 from $140 at Oppenheimer - TipRanks
American Century Companies Inc. Has $9.70 Million Position in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
AB Capital breaks out from inverse Head & Shoulder pattern; time to buy? - The Economic Times
ProShare Advisors LLC Acquires 127,133 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Heron Bay Capital Management - Defense World
Is AbbVie (NYSE:ABBV) A Risky Investment? - Yahoo Finance
ABIVAX Société Anonyme (NASDAQ:ABVX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Huber Capital Management LLC Has $1.62 Million Stock Holdings in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Callan Capital LLC - Defense World
Abbott Laboratories (NYSE:ABT) Shares Purchased by Ensign Peak Advisors Inc - MarketBeat
Anheuser-Busch InBev SA/NV (NYSE:BUD) Stake Increased by Moors & Cabot Inc. - Defense World
XTX Topco Ltd Invests $2.09 Million in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Envestnet Asset Management Inc. Has $35.56 Million Position in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Ieq Capital LLC Purchases 2,154 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
AbbVie’s Elahere gets CHMP nod as competition advances - BioCentury
Here's Why Abbott (ABT) Fell More Than Broader Market - Yahoo Finance
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
AbbVie (NYSE:ABBV) Trading Down 0.3% - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Down 0.1% - MarketBeat
Agilent Completes Acquisition of BIOVECTRA – Company Announcement - Financial Times
SYSTM Wealth Solutions LLC Has $117,000 Holdings in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Abbvie Slides on ELAHERE Opinion of its Cancer Treatment - Baystreet.ca
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance
Edgestream Partners L.P. Raises Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
2.88%
2.65%
자본화:
|
볼륨(24시간):